Richard Payerchin

Biden reveals aggressive prostate cancer that has metastasized to his bones.

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

House Budget Committee takes up debate and AMGA publishes projections due to Medicaid cuts in One Big Beautiful Bill Act.

Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.

Congressional committees review spending with Health and Human Services Department leader.

Public health experts react to HHS Secretary Robert F. Kennedy’s testimony of budget in House of Representatives.

Robert F. Kennedy Jr. testifies about HHS budget before House Appropriations Committee.

House committee begins deliberations on federal budget reconciliation bill, which includes Medicaid.

Energy & Commerce Chair Rep. Brett Guthrie spells out need for changes to Medicaid.

Three House committee leaders speak out on spending plan up for debate today.

Republican committee chair says Medicaid claims are unfounded, but advocacy groups, Democrats are predicting dire consequences.

Panel discusses need for communication and importance of primary care in relation to oncology and cancer treatments.

Ultraprocessed foods, oil-based dyes are FDA targets as part of Make America Healthy Again initiative.

Make America Healthy Again, HHS all on the agenda this week in U.S. Senate.

National Comprehensive Cancer Network holds policy summit on collaboration in oncology, primary care.